MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis

PLoS ONE

Volumn 4, Issue 10, 2009, Pages

  Vasilescu, Catalin ^a   Rossi, Simona ^b   Shimizu, Masayohi ^b   Tudor, Stefan ^a   Veronese, Angelo ^c   Ferracin, Manuela ^c   Nicoloso, Milena S ^b   Barbarotto, Elisa ^b   Popa, Monica ^a   Stanciulea, Oana ^a   Fernandez, Michael H ^b   Tulbure, Dan ^a   Bueso Ramos, Carlos E ^b   Negrini, Massimo ^c   Calin, George A ^b  

^a FUNDENI CLINICAL INSTITUTE   (Romania)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 150; MICRORNA 182; MICRORNA 342 5P; MICRORNA 486; UNCLASSIFIED DRUG; INTERLEUKIN 10; INTERLEUKIN 18; MIRN150 MICRORNA, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE EXPRESSION PROFILING; HUMAN; MALE; MICROARRAY ANALYSIS; PROGNOSIS; PROTEIN BLOOD LEVEL; QUANTITATIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA FINGERPRINTING; SCORING SYSTEM; SEPSIS; BLOOD; DNA MICROARRAY; METABOLISM; MICROBIOLOGY; MIDDLE AGED; MORTALITY; PROSPECTIVE STUDY; TREATMENT OUTCOME;

AGED; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-18; MALE; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROSPECTIVE STUDIES; SEPSIS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70350714526     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007405     Document Type: Article

References (35)

1. Hotchkiss RS, Karl IE (2003) The pathophysiology and treatment of sepsis. N Engl J Med 348: 138-150.
2. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, et al. (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101: 1644-1655.
3. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL (2003) Rapid increase in hospitalization and DEADality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med 35: 1244-50.
4. Hutchins RR, Gunning PM, Lucas DN, Allen-Mersh TG, Soni NC (2004) Relaparotomy for suspected intraperitoneal sepsis after abdominal surgery. World J Surg 28: 137-141.
5. Lichtenstern C, Schmidt J, Knaebel HP, Martin E, Büchler MW, et al. (2007) Postoperative Bacterial/Fungal Infections: A Challenging Problem in Critically Ill Patients after Abdominal Surgery. Dig Surg 24: 1-11.
6. Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866.
7. Nicoloso MS, Spizzo R, Shimizu M, Rossi S, Calin GA (2009) MicroRNAs - The micro steering wheel of tumor metastases. Nat Rev Cancer 9: 293-302.
8. Perkins DO, Jeffries CD, Jarskog LF, Thomson JM, Woods K, et al. (2007) microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biol 8: R27.
9. Wang Q, Wang Y, Minto AW, Wang J, Shi Q, et al. (2008) MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy. FASEB J 22: 4126-4135.
10. Wu F, Zikusoka M, Trindade A, Dassopoulos T, Harris ML, et al. (2008) MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. Gastroenterology 135: 1624-1635.
11. Anglicheau D, Sharma VK, Ding R, Hummel A, Snopkowski C, et al. (2009) MicroRNA expression profiles predictive of human renal allograft status. Proc Natl Acad Sci U S A 106: 5330-5335.
12. Ambros V (2004) The functions of animal microRNAs. Nature 431: 350-355.
13. Tili E, Michaille JJ, Cimino A, Costinean S, Dumitru CD, et al. (2007) Modulation of miR-155 and miR-125b levels following lipopolysaccharide/ TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 179: 5082-5089.
14. Cortez A, Calin GA (2009) MicroRNA identification in plasma and serum: a novel tool to diagnose and monitor diseases. Expert Opinion in Biological Therapy 9: 703-711.
15. Grobmyer SR, Lin E, Lowry SF, Rivadeneira DE, Potter S, et al. (2000) Elevation of IL-18 in human sepsis. J Clin Immunol 20: 212-215.
16. Oberholzer A, Steckholzer U, Kurimoto M, Trentz O, Ertel W (2001) Interleukin-18 plasma levels are increased in patients with sepsis compared to severely injured patients. Shock 16: 411-414.
17. ZakiMel-S, Elgendy MY, El-Mashad NB, Farahat ME (2007) IL-18 level correlates with development of sepsis in surgical patients. Immunol Invest 36: 403-411.
18. Pereira C, Schaer DJ, Bachli EB, Kurrer MO, Schoedon G (2008) Wnt5A/ CaMKII signaling contributes to the inflammatory response of macrophages and is a target for the antiinflammatory action of activated protein C and interleukin-10. Arterioscler Thromb Vasc Biol 28: 504-510.
19. George SJ (2008) Wnt pathway: a new role in regulation of inflammation. Arterioscler Thromb Vasc Biol 28: 400-402.
20. Das S, Misra B, Roul L, Minz NT, Pattnaik M, Baig MA (2008) Insulin Resistance and beta Cell Function As Prognostic Indicator in Multi-Organ Dysfunction Syndrome. Metab Syndr Relat Disord.
21. Barkhausen T, Probst C, Hildebrand F, Pape HC, Krettek C, van Griensven M (2009) Insulin therapy induces changes in the inflammatory response in a murine 2-hit model. Injury.
22. Koff JL, Shao MX, Ueki IF, Nadel JA (2008) Multiple TLRs activate EGFR via a signaling cascade to produce innate immune responses in airway epithelium. Am J Physiol Lung Cell Mol Physiol 294: L1068-1075.
23. Weichhart T, G. Costantino G, Poglitsch M, Rosner M, Zeyda M, et al. (2008) The TSC-mTOR signaling pathway regulates the innate inflammatory response. Immunity 29: 565-577.
24. Németh K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, et al. (2009) Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 15: 42-49.
25. Abe R, Hirasawa H, Oda S, Sadahiro T, Nakamura M, et al. (2008) Up-regulation of interleukin-10 mRNA expression in peripheral leukocytes predicts poor outcome and diminished human leukocyte antigen-DR expression on monocytes in septic patients. J Surg Res 147: 1-8.
26. Libert C (2003) Inflammation: A nervous connection. Nature 421: 328-329.
27. Schmidt WM, Spiel AO, Jilma B, Wolzt M, Müller M (2009) In vivo profile of the human leukocyte microRNA response to endotoxemia. Biochem Biophys Res Commun 380: 437-441.
28. Xiao C, Calado DP, Galler G, Thai TH, Patterson HC, et al. (2007) MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 131: 146-159.
29. Fredriksson K, Tjäder I, Keller P, Petrovic N, Ahlman B, et al. (2008) Dysregulation of mitochondrial dynamics and the muscle transcriptome in ICU patients suffering from sepsis-induced multiple organ failure. PLoS ONE 3: e3686.
30. Minne L, Abu-Hanna A, de Jonge E (2008) Evaluation of SOFA-based models for predicting mortality in the ICU: A systematic review. Crit Care 12(6): R161.
31. Hotchkiss RS, Nicholson DW (2006) Apoptosis and caspases regulate death and inflammation in sepsis. Nat Rev Immunol 6: 813-822.
32. Hotchkiss RS, Tinsley KW, Swanson PE, Schmieg Jr RE, Hui JJ, et al. (2001) Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J Immunol 166: 6952-6963.
33. Hotchkiss RS, Tinsley KW, Swanson PE, Grayson MH, Osborne DF, et al. (2002) Depletion of dendritic cells, but not macrophages, in patients with sepsis. J Immunol 168: 2493-2500.
34. Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD (2008) MicroRNAs: new regulators of immune cell development and function. Nat Immunol 9: 839-845.
35. Tili E, Michaille JJ, Calin GA (2008) Expression and function of micro-RNAs in immune cells during normal or disease state. Int J Med Sci 5: 73-79.